French industry lobbies hard over tough device marketing conditions
This article was originally published in Clinica
Executive Summary
The ongoing reform of funding and reimbursement in the French healthcare system, particularly the introduction of the new DRG scheme, is creating a number of pressures on the devices industry as it struggles to persuade a government intent on cutting costs to take a more rational approach. Odile Corbin, general manager of French medtech industry association SNITEM, told Clinica's Amanda Maxwell about the issues on which the industry is having to concentrate its lobbying efforts.